Comparison of the effects of five dietary fibers on mucosal transcriptional profiles, and luminal microbiota composition and SCFA concentrations in murine colon

Molecular Nutrition and Food Research

Volumn 59, Issue 8, 2015, Pages 1590-1602

  Lange, Katja ^a,b   Hugenholtz, Floor ^a,b   Jonathan, Melliana C ^a   Schols, Henk A ^a,c   Kleerebezem, Michiel ^a,b,c   Smidt, Hauke ^a,b,c   Müller, Michael ^a,b,d   Hooiveld, Guido J E J ^a,b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b Netherlands Consortium for Systems Biology   (Netherlands)

^c TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Colon; Dietary fiber; Gut health; Microbiota; Transcriptomics

Indexed keywords

CLOSTRIDIUM; MURINAE; MUS;

ARABINOXYLAN; FRUCTOSE OLIGOSACCHARIDE; GALACTAN; GUAR GUM; INULIN; MANNAN; OLIGOSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT GUM; STARCH; VOLATILE FATTY ACID; XYLAN;

ANIMAL; C57BL MOUSE; CLASSIFICATION; CLOSTRIDIUM; COLON; COMPARATIVE STUDY; DIETARY FIBER; ENERGY METABOLISM; ENZYMOLOGY; FERMENTATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; INTESTINE FLORA; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; MOLECULAR TYPING;

ANIMALS; CLOSTRIDIUM; COLON; DIETARY FIBER; ENERGY METABOLISM; FATTY ACIDS, VOLATILE; FERMENTATION; GALACTANS; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTESTINAL MUCOSA; INULIN; MALE; MANNANS; MICE, INBRED C57BL; MOLECULAR TYPING; OLIGOSACCHARIDES; PLANT GUMS; PPAR GAMMA; STARCH; XYLANS;

EID: 84938547558     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400597     Document Type: Article

References (61)

1. Phillips, G. O., Cui, S. W., An introduction: evolution and finalisation of the regulatory definition of dietary fibre. Food Hydrocoll. 2011, 25, 139-143.
2. Jones, J. M., CODEX-aligned dietary fiber definitions help to bridge the 'fiber gap'. Nutr. J. 2014, 13, 34.
3. Aune, D., Chan, D. S., Lau, R., Vieira, R. et al., Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 2011, 343, d6617.
4. Balakrishnan, M., Floch, M. H., Prebiotics, probiotics and digestive health. Curr Opin. Clin. Nutr. Metab. Care 2012, 15, 580-585.
5. Slavin, J. L., Fiber and prebiotics: mechanisms and health benefits. Nutrients 2013, 5, 1417-1435.
6. Eswaran, S., Muir, J., Chey, W. D., Fiber and functional gastrointestinal disorders. Am. J. Gastroenterol. 2013, 108, 718-727.
7. Nyangale, E. P., Mottram, D. S., Gibson, G. R., Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J. Proteome Res. 2012, 11, 5573-5585.
8. Russell, W. R., Hoyles, L., Flint, H. J., Dumas, M. E., Colonic bacterial metabolites and human health. Curr. Opin. Microbiol. 2013, 16, 246-254.
9. Flint, H. J., Bayer, E. A., Rincon, M. T., Lamed, R. et al., Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat. Rev. Microbiol. 2008, 6, 121-131.
10. Van den Abbeele, P., Gerard, P., Rabot, S., Bruneau, A. et al., Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats. Environ. Microbiol. 2011, 13, 2667-2680.
11. Van den Abbeele, P., Venema, K., Van de Wiele, T., Verstraete, W. et al., Different human gut models reveal the distinct fermentation patterns of Arabinoxylan versus inulin. J. Agric. Food Chem. 2013, 61, 9819-9827.
12. El Kaoutari, A., Armougom, F., Gordon, J. I., Raoult, D. et al., The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat. Rev. Microbiol. 2013, 11, 497-504.
13. Hooper, L. V., Midtvedt, T., Gordon, J. I., How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 2002, 22, 283-307.
14. Barboza, M., Sela, D. A., Pirim, C., Locascio, R. G. et al., Glycoprofiling bifidobacterial consumption of galacto-oligosaccharides by mass spectrometry reveals strain-specific, preferential consumption of glycans. Appl. Environ. Microbiol. 2009, 75, 7319-7325.
15. Riviere, A., Moens, F., Selak, M., Maes, D. et al., The ability of bifidobacteria to degrade arabinoxylan oligosaccharide constituents and derived oligosaccharides is strain dependent. Appl. Environ. Microbiol. 2014, 80, 204-217.
16. Müller, M., Kersten, S., Nutrigenomics: goals and strategies. Nat. Rev. Genet. 2003, 4, 315-322.
17. Afman, L., Muller, M., Nutrigenomics: from molecular nutrition to prevention of disease. J. Am. Diet Assoc. 2006, 106, 569-576.
18. Keenan, M. J., Martin, R. J., Raggio, A. M., McCutcheon, K. L. et al., High-amylose resistant starch increases hormones and improves structure and function of the gastrointestinal tract: a microarray study. J. Nutrigenet. Nutrigenomics 2012, 5, 26-44.
19. Haenen, D., Souza da Silva, C., Zhang, J., Koopmans, S. J. et al., Resistant starch induces catabolic but suppresses immune and cell division pathways and changes the microbiome in the proximal colon of male pigs. J. Nutr. 2013, 143, 1889-1898.
20. Rodenburg, W., Keijer, J., Kramer, E., Vink, C. et al., Impaired barrier function by dietary fructo-oligosaccharides (FOS) in rats is accompanied by increased colonic mitochondrial gene expression. BMC Genom. 2008, 9, 144.
21. Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E. et al., The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 2009, 1, 6ra14.
22. Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B. et al., Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5, R80.
23. Lin, K., Kools, H., de Groot, P. J., Gavai, A. K. et al., MADMAX - Management and analysis database for multiple ∼omics experiments. J. Integr. Bioinform. 2011, 8, 160.
24. Piccolo, S. R., Withers, M. R., Francis, O. E., Bild, A. H. et al., Multiplatform single-sample estimates of transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 17778-17783.
25. Smyth, G. K., Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3, 1-25.
26. Sartor, M. A., Tomlinson, C. R., Wesselkamper, S. C., Sivaganesan, S. et al., Intensity-based hierarchical Bayes method improves testing for differentially expressed genes in microarray experiments. BMC Bioinform. 2006, 7, 538.
27. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S. et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 15545-15550.
28. Allison, D. B., Cui, X., Page, G. P., Sabripour, M., Microarray data analysis: from disarray to consolidation and consensus. Nat. Rev. Genet. 2006, 7, 55-65.
29. Abatangelo, L., Maglietta, R., Distaso, A., D'Addabbo, A. et al., Comparative study of gene set enrichment methods. BMC Bioinform. 2009, 10, 275.
30. Merico, D., Isserlin, R., Stueker, O., Emili, A. et al., Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One 2010, 5, e13984.
31. Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q. et al., Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 2013, 14, 128.
32. Yu, Z., Morrison, M., Improved extraction of PCR-quality community DNA from digesta and fecal samples. Biotechniques 2004, 36, 808-812.
33. Geurts, L., Lazarevic, V., Derrien, M., Everard, A. et al., Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front Microbiol. 2011, 2, 149.
34. Lahti, L., Torrente, A., Elo, L. L., Brazma, A. et al., A fully scalable online pre-processing algorithm for short oligonucleotide microarray atlases. Nucleic Acids Res. 2013, 41, e110.
35. Lepš, J., Šmilauer, P., Multivariate Analysis of Ecological Data using CANOCO, Cambridge University Press, Cambridge, UK 2003.
36. Haenen, D., Zhang, J., Souza da Silva, C., Bosch, G. et al., A diet high in resistant starch modulates microbiota composition, SCFA concentrations, and gene expression in pig intestine. J. Nutr. 2013, 143, 274-283.
37. Jonathan, M. C., van den Borne, J. J. G. C., van Wiechen, P., Souza da Silva, C. et al., In vitro fermentation of 12 dietary fibres by faecal inoculum from pigs and humans. Food Chem. 2012, 133, 889-897.
38. Boulesteix, A. L., Strimmer, K., Partial least squares: a versatile tool for the analysis of high-dimensional genomic data. Brief Bioinform. 2007, 8, 32-44.
39. Le Cao, K. A., Martin, P. G., Robert-Granie, C., Besse, P., Sparse canonical methods for biological data integration: application to a cross-platform study. BMC Bioinform. 2009, 10, 34.
40. Kucera, M., Malmgren, B. A., Logratio transformation of compositional data: a resolution of the constant sum constraint. Mar. Micropaleontol. 1998, 34, 117-120.
41. Fernandes, A. D., Reid, J. N., Macklaim, J. M., McMurrough, T. A. et al., Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis. Microbiome 2014, 2, 15.
42. Gonzalez, I., Cao, K. A., Davis, M. J., Dejean, S., Visualising associations between paired 'omics' data sets. BioData Min. 2012, 5, 19.
43. Le Cao, K. A., Gonzalez, I., Dejean, S., integrOmics: an R package to unravel relationships between two omics datasets. Bioinformatics 2009, 25, 2855-2856.
44. Topping, D. L., Clifton, P. M., Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 2001, 81, 1031-1064.
45. Vanhoutvin, S. A., Troost, F. J., Hamer, H. M., Lindsey, P. J. et al., Butyrate-induced transcriptional changes in human colonic mucosa. PLoS One 2009, 4, e6759.
46. Fung, K. Y., Cosgrove, L., Lockett, T., Head, R. et al., A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br. J. Nutr. 2012, 108, 820-831.
47. Roediger, W. E., Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 1982, 83, 424-429.
48. Donohoe, D. R., Garge, N., Zhang, X., Sun, W. et al., The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011, 13, 517-526.
49. Donohoe, D. R., Wali, A., Brylawski, B. P., Bultman, S. J., Microbial regulation of glucose metabolism and cell-cycle progression in mammalian colonocytes. PLoS One 2012, 7, e46589.
50. Davies, K. J., Oxidative stress: the paradox of aerobic life. Biochem. Soc. Symp. 1995, 61, 1-31.
51. Klaassen, C. D., Reisman, S. A., Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver. Toxicol. Appl. Pharmacol. 2010, 244, 57-65.
52. Yaku, K., Enami, Y., Kurajyo, C., Matsui-Yuasa, I. et al., The enhancement of phase 2 enzyme activities by sodium butyrate in normal intestinal epithelial cells is associated with Nrf2 and p53. Mol. Cell Biochem. 2012, 370, 7-14.
53. Zeng, H., Lazarova, D. L., Bordonaro, M., Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention. World J. Gastrointest. Oncol. 2014, 6, 41-51.
54. Abell, G. C., Cooke, C. M., Bennett, C. N., Conlon, M. A. et al., Phylotypes related to Ruminococcus bromii are abundant in the large bowel of humans and increase in response to a diet high in resistant starch. FEMS Microbiol. Ecol. 2008, 66, 505-515.
55. Ze, X., Duncan, S. H., Louis, P., Flint, H. J., Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J. 2012, 6, 1535-1543.
56. Su, W., Bush, C. R., Necela, B. M., Calcagno, S. R. et al., Differential expression, distribution, and function of PPAR-gamma in the proximal and distal colon. Physiol. Genomics 2007, 30, 342-353.
57. Alex, S., Lange, K., Amolo, T., Grinstead, J. S. et al., Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor gamma. Mol. Cell Biol. 2013, 33, 1303-1316.
58. Dubuquoy, L., Rousseaux, C., Thuru, X., Peyrin-Biroulet, L. et al., PPARgamma as a new therapeutic target in inflammatory bowel diseases. Gut 2006, 55, 1341-1349.
59. Hou, Y., Moreau, F., Chadee, K., PPARgamma is an E3 ligase that induces the degradation of NFkappaB/p65. Nat. Commun. 2012, 3, 1300.
60. Louis, P., Flint, H. J., Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 2009, 294, 1-8.
61. den Besten, G., Havinga, R., Bleeker, A., Rao, S. et al., The short-chain fatty acid uptake fluxes by mice on a guar gum supplemented diet associate with amelioration of major biomarkers of the metabolic syndrome. PLoS One 2014, 9, e107392.